UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe?

Journal of the American College of Surgeons, 2021-08, Vol.233 (2), p.285-293

2021

Volltextzugriff (PDF)

Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast

Annals of surgical oncology, 2007-10, Vol.14 (10), p.2961-2970

2007

Volltextzugriff (PDF)

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy

Annals of surgical oncology, 2020-10, Vol.27 (11), p.4515-4522

2020

Volltextzugriff (PDF)

How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?

Annals of surgical oncology, 2021-01, Vol.28 (1), p.287-294

2021

Volltextzugriff (PDF)

Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers

NPJ breast cancer, 2024-07, Vol.10 (1), p.63-7, Article 63

2024

Volltextzugriff (PDF)

Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6133-6139

2022

Volltextzugriff (PDF)

Managing the Morbidity: Individualizing Risk Assessment, Diagnosis, and Treatment Options for Upper Extremity Lymphedema

Surgical oncology clinics of North America, 2023-10, Vol.32 (4), p.705-724

2023

Volltextzugriff (PDF)

ASO Author Reflections: To Dissect or Not to Dissect—The Clinical Implications of Microscopic Extracapsular Extension in the Sentinel Node

Annals of surgical oncology, 2020-05, Vol.27 (5), p.1625-1626

2020

Volltextzugriff (PDF)

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

NPJ breast cancer, 2022-03, Vol.8 (1), p.37-37, Article 37

2022

Volltextzugriff (PDF)

Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?

Cancer, 2022-02, Vol.128 (3), p.471-478

2022

Volltextzugriff (PDF)

ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors

Annals of surgical oncology, 2020-12, Vol.27 (Suppl 3), p.755-756

2020

Volltextzugriff (PDF)

Controversies in the Treatment of Ductal Carcinoma in Situ

Annual review of medicine, 2017-01, Vol.68, p.197

2017

Volltextzugriff (PDF)

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

Annals of surgical oncology, 2016-10, Vol.23 (11), p.3467-3474

2016

Volltextzugriff (PDF)

ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer

Annals of surgical oncology, 2022-12, Vol.29 (13), p.8012-8013

2022

Volltextzugriff (PDF)

ASO Author Reflections: Acute or Chronic? The Effect of Axillary Lymph Node Dissection on Arm Symptoms and Quality of Life Over Time

Annals of surgical oncology, 2022-07, Vol.29 (7), p.4137-4138

2022

Volltextzugriff (PDF)

A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.370-375

2015

Volltextzugriff (PDF)

The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype

Annals of surgical oncology, 2017-11, Vol.24 (12), p.3527-3533

2017

Volltextzugriff (PDF)

Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities

Surgery, 2015-10, Vol.158 (4), p.946-953

2015

Volltextzugriff (PDF)

Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

Annals of surgical oncology, 2022-12, Vol.29 (13), p.8037-8043

2022

Volltextzugriff (PDF)

Longitudinal Prospective Evaluation of Quality of Life After Axillary Lymph Node Dissection

Annals of surgical oncology, 2022-04, Vol.29 (7), p.4127-4136

2022

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?

Annals of surgical oncology, 2022-12, Vol.29 (13), p.8002-8011

2022

Volltextzugriff (PDF)

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema

JAMA oncology, 2022-08, Vol.8 (8), p.1195

2022

Volltextzugriff (PDF)

Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients

Annals of surgery, 2017-09, Vol.266 (3), p.457-462

2017

Volltextzugriff (PDF)

ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6142-6143

2022

Volltextzugriff (PDF)

ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

Annals of surgical oncology, 2022-12, Vol.29 (13), p.8046-8047

2022

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(96)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe?

Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy

How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?

Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers

Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

Managing the Morbidity: Individualizing Risk Assessment, Diagnosis, and Treatment Options for Upper Extremity Lymphedema

ASO Author Reflections: To Dissect or Not to Dissect—The Clinical Implications of Microscopic Extracapsular Extension in the Sentinel Node

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?

ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors

Controversies in the Treatment of Ductal Carcinoma in Situ

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer

ASO Author Reflections: Acute or Chronic? The Effect of Axillary Lymph Node Dissection on Arm Symptoms and Quality of Life Over Time

A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema

The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype

Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities

Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

Longitudinal Prospective Evaluation of Quality of Life After Axillary Lymph Node Dissection

Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema

Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients

ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

Suchergebnisse filtern